文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

淋巴细胞作为一种活的癌症药物。

Lymphocytes as a living drug for cancer.

机构信息

National Cancer Institute, Bethesda, MD, USA.

出版信息

Science. 2024 Jul 5;385(6704):25-26. doi: 10.1126/science.adp1130. Epub 2024 Jul 4.

DOI:10.1126/science.adp1130
PMID:38963837
Abstract

Using a patient's lymphocytes is approved to treat melanoma and has wider applications.

摘要

利用患者的淋巴细胞治疗黑色素瘤已获批准，且具有更广泛的应用。

相似文献

[1]
Lymphocytes as a living drug for cancer.

Science. 2024-7-5

[2]
Adoptive T-cell therapy for cancer: boutique therapy or treatment modality?

Clin Cancer Res. 2013-8-6

[3]
Tumor-infiltrating lymphocytes in melanoma.

Curr Oncol Rep. 2012-10

[4]
Adoptive transfer of tumor-infiltrating lymphocytes in patients with metastatic melanoma: intent-to-treat analysis and efficacy after failure to prior immunotherapies.

Clin Cancer Res. 2013-5-20

[5]
Adoptive T cell therapy: An overview of obstacles and opportunities.

Cancer. 2017-6-1

[6]
Adoptive transfer of tumor-infiltrating lymphocytes in melanoma: a viable treatment option.

J Immunother Cancer. 2018-10-3

[7]
Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook.

Cancer J. 2012

[8]
Adoptive cell therapy for patients with melanoma, using tumor-infiltrating lymphocytes genetically engineered to secrete interleukin-2.

Hum Gene Ther. 2008-5

[9]
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression.

Clin Cancer Res. 2017-5-15

[10]
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy.

Cancer Immunol Immunother. 2021-6

引用本文的文献

[1]
Editorial: Community series in biomarkers in the era of cancer immunotherapy: zooming in from periphery to tumor microenvironment, volume II.

Front Immunol. 2025-8-1

[2]
Engineered human B cells targeting tumor-associated antigens exhibit antigen presentation and antibody-mediated functions.

Front Immunol. 2025-7-30

[3]
Lifileucel (AMTAGVI) tumor-infiltrating lymphocyte morphology in CellaVision peripheral smear reviews.

J Hematop. 2025-3-26

[4]
The evolution of cancer immunotherapy: a comprehensive review of its history and current perspectives.

Korean J Clin Oncol. 2024-12

[5]
Tumor-infiltrating lymphocytes in melanoma: from prognostic assessment to therapeutic applications.

Front Immunol. 2024-12-6

[6]
Next-generation immunotherapy: igniting new hope for lung cancer.

Ther Adv Med Oncol. 2024-12-7

[7]
CD4 tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts.

Oncoimmunology. 2024

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索